A pathway-directed positive growth restoration assay to facilitate the discovery of lipid A and fatty acid biosynthesis inhibitors in Acinetobacter baumannii-Reference-Cited by-同舟云学术

A pathway-directed positive growth restoration assay to facilitate the discovery of lipid A and fatty acid biosynthesis inhibitors in Acinetobacter baumannii

Published:2018-03-05 Issue:3 Volume:13 Page:e0193851
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Richie Daryl L.^ORCID,Wang Lisha,Chan Helen,De Pascale Gianfranco,Six David A.,Wei Jun-Rong,Dean Charles R.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference92 articles.

1. Public funding of clinical-stage antibiotic development in the United States and European Union;MJ Eichberg;Health Secur,2015

2. Biogenesis of the gram-negative bacterial outer membrane;MP Bos;Annu Rev Microbiol,2007

3. What is an "ideal" antibiotic? Discovery challenges and path forward;SB Singh;Biochem Pharmacol,2017

4. Challenges of antibacterial discovery;LL Silver;Clin Microbiol Rev,2011

5. Drug discovery strategies to outer membrane targets in Gram-negative pathogens;DG Brown;Bioorg Med Chem,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements of carbon quantum dots for biological applications;Carbon and Graphene Quantum Dots for Biomedical Applications;2023

2. Constitutive Phenotypic Modification of Lipid A in Clinical Acinetobacter baumannii Isolates;Microbiology Spectrum;2022-08-31

3. Rapid Inhibitor Discovery by Exploiting Synthetic Lethality;Journal of the American Chemical Society;2022-02-16

4. Border Control: Regulating LPS Biogenesis;Trends in Microbiology;2021-04

5. Afabicin. Enoyl-(acyl-carrier-protein) reductase FabI inhibitor, Antibacterial drug;Drugs of the Future;2021